Mode
Text Size
Log in / Sign up

Gut-liver axis models evolve from static co-cultures to microfluidic systems, review findsNew models aim to mimic gut-liver crosstalk in lab

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that gut-liver axis models are advancing but face technical and biological gaps before clinical translation.

This narrative review examines the evolution of in vitro models for studying the gut-liver axis, ranging from static co-cultures to advanced microfluidic systems. The authors synthesize the current state of the field, highlighting the progression toward more physiologically relevant platforms that better recapitulate interorgan interactions.

Key findings include the identification of several underexplored areas: metabolite-mediated gut-liver crosstalk, immune-mediated interorgan communication, and disease-specific modeling. These gaps represent opportunities for future research to enhance understanding of gut-liver physiology and pathology.

The review also acknowledges technical challenges that remain, particularly in achieving physiologically faithful and reliable integrated platforms. These limitations underscore the difficulty of translating complex in vivo interactions into robust in vitro systems.

While the review provides a useful overview of model systems, it does not offer quantitative comparisons or clinical recommendations. The findings are most relevant for researchers developing or selecting gut-liver axis models, rather than for direct clinical application.

A new review looks at the latest ways scientists are trying to recreate the conversation between the gut and the liver in the lab. These models range from simple cell cultures to more advanced microfluidic devices that mimic the body's environment. The goal is to better understand how these two organs influence each other in health and disease.

The review points out that while progress has been made, there are still big gaps. For example, researchers don't yet fully understand how metabolites (substances made during digestion) travel between the gut and liver, or how the immune system plays a role in their communication. Also, building models that truly copy what happens in the body is technically very hard.

This is a review of existing research, not a new study with patients. It highlights where the field is and where it needs to go. For now, these models are tools for scientists, not something that changes medical care right away.

Readers should know that this is early-stage work. It helps researchers ask better questions, but it is not ready to guide treatment or diagnosis.

What this means for you:
Lab models of gut-liver crosstalk are improving but still miss key biological details.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
The gut-liver axis maintains metabolic homeostasis and immune regulation through continuous bidirectional communication, and its dysregulation contributes to a range of metabolic, inflammatory, and immune-mediated diseases. Integrated gut-liver axis model systems offer unique tools for dissecting these complex interactions by isolating individual variables that are difficult to disentangle in vivo, while allowing flexible experimental controls over them. Here, we review advances in gut-liver axis models from static co-cultures to microfluidic systems and their applications in pharmacokinetic and mechanistic studies. We identify underexplored areas, including metabolite-mediated gut-liver crosstalk, immune-mediated interorgan communication, and disease-specific modeling, and outline technical challenges to achieving physiologically faithful and reliable integrated platforms. By addressing these challenges, gut-liver axis models will contribute to a mechanistic understanding of gut-liver pathobiology that is difficult to achieve through clinical studies, animal models, or individual organ systems alone.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.